Acetazolamide for Treatment Resistant Schizophrenia

Clinical trial NCT04887792 · RECRUITING

Trial details

NCT number: NCT04887792
Sponsor: Vishwajit Nimgaonkar, MD PhD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizo Affective Disorder

Start date: 2022-02-01
Primary completion: 2027-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.